TSVQX
Price
$23.68
Change
+$0.12 (+0.51%)
Updated
Sep 3 closing price
Net Assets
431.59M
VISVX
Price
$59.23
Change
+$0.03 (+0.05%)
Updated
Sep 4 closing price
Net Assets
68.22B
Interact to see
Advertisement

TSVQX vs VISVX

TSVQX vs VISVX Comparison Chart in %
View a ticker or compare two or three
VS
TSVQX vs. VISVX commentary
Sep 05, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is TSVQX is a Buy and VISVX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VISVX has more cash in the bank: 68.2B vs. TSVQX (432M). VISVX pays higher dividends than TSVQX: VISVX (1.64) vs TSVQX (0.83). TSVQX was incepted earlier than VISVX: TSVQX (12 years) vs VISVX (28 years). TSVQX (0.69) is less costly to investors than VISVX (0.19). TSVQX is a more actively managed with annual turnover of: 122.00 vs. VISVX (25.00). TSVQX (0) and VISVX (0) have matching initial minimum investment requirements. TSVQX annual gain was more profitable for investors over the last year : 30.10 vs. VISVX (18.06). VISVX return over 5 years is better than : 44.17 vs. TSVQX (19.86).
TSVQXVISVXTSVQX / VISVX
Total Expense Ratio0.680.19358%
Annual Report Gross Expense Ratio0.690.19363%
Fund Existence12 years28 years-
Gain YTD23.93516.796143%
Front LoadN/AN/A-
Min. Initial Investment00-
Min. Initial Investment IRAN/AN/A-
Net Assets432M68.2B1%
Annual Yield % from dividends0.831.6451%
Returns for 1 year30.1018.06167%
Returns for 3 years43.2450.7685%
Returns for 5 years19.8644.1745%
Returns for 10 years49.69130.4238%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BTAI0.120.01
+9.81%
BioXcel Therapeutics Inc
CG47.750.61
+1.29%
Carlyle Group (The)
FUSB16.550.10
+0.61%
First US Bancshares
PPLI38.960.05
+0.13%
People Incorporated
RGR37.22-0.76
-2.00%
Sturm Ruger & Company